Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Bone and Joint Surgery. American Volume
|
March 27, 2001
Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture
H Dorai, T K Sampath
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1987
The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes
H Dorai, G P Moore
Journal of Cellular Physiology
|
May 29, 2000
Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro
H Dorai, S Vukicevic, T K Sampath
Molecular Immunology
|
December 1, 1992
Role of inter-heavy and light chain disulfide bonds in the effector functions of human immunoglobulin IgG1
H Dorai, J S Wesolowski, S D Gillies
Hybridoma
|
October 1, 1992
Cloning and reexpression of a functional human IgM anti-lipid A antibody
H Dorai, J E Bubbers, S D Gillies
Molecular and Cellular Biology
|
October 1, 1982
Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity
B S Schaffhausen, H Dorai, G Arakere, et al.
Hybridoma
|
April 1, 1991
Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function
H Dorai, B M Mueller, R A Reisfeld, et al.
Biochemical and Biophysical Research Communications
|
June 13, 2001
The 5' flanking region of the human bone morphogenetic protein-7 gene
H Dorai, A Shepard, E Ozkaynak, et al.
Bio/Technology (Nature Publishing Company)
|
September 1, 1994
Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains
H Dorai, J E McCartney, R M Hudziak, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1986
A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen
B G Sahagan, H Dorai, J Saltzgaber-Muller, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Bone and Joint Surgery. American Volume
|
March 27, 2001
Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture
H Dorai, T K Sampath
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1987
The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes
H Dorai, G P Moore
Journal of Cellular Physiology
|
May 29, 2000
Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro
H Dorai, S Vukicevic, T K Sampath
Molecular Immunology
|
December 1, 1992
Role of inter-heavy and light chain disulfide bonds in the effector functions of human immunoglobulin IgG1
H Dorai, J S Wesolowski, S D Gillies
Hybridoma
|
October 1, 1992
Cloning and reexpression of a functional human IgM anti-lipid A antibody
H Dorai, J E Bubbers, S D Gillies
Molecular and Cellular Biology
|
October 1, 1982
Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity
B S Schaffhausen, H Dorai, G Arakere, et al.
Hybridoma
|
April 1, 1991
Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function
H Dorai, B M Mueller, R A Reisfeld, et al.
Biochemical and Biophysical Research Communications
|
June 13, 2001
The 5' flanking region of the human bone morphogenetic protein-7 gene
H Dorai, A Shepard, E Ozkaynak, et al.
Bio/Technology (Nature Publishing Company)
|
September 1, 1994
Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains
H Dorai, J E McCartney, R M Hudziak, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1986
A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen
B G Sahagan, H Dorai, J Saltzgaber-Muller, et al.
Page
of 2